The DOI matches its Crossref record; 484 of the 484 references it cites were found in a registry or an index.
The Phosphoinositide 3-Kinase Pathway in Human Cancer: Genetic Alterations and Therapeutic Implications
Open accessAbstract
The phosphoinositide 3-kinase (PI3K) pathway is frequently activated in human cancer and represents an attractive target for therapies based on small molecule inhibitors. PI3K isoforms play an essential role in the signal transduction events activated by cell surface receptors including receptor tyrosine kinases (RTKs) and G-protein-coupled receptors (GPCRs). There are eight known PI3K isoforms in humans, which have been subdivided into three classes (I-III). Therefore PI3Ks show considerable diversity and it remains unclear which kinases in this family should be targeted in cancer. The class I(A) of PI3K comprises the p110alpha, p110beta and p110delta isoforms, which associate with activated RTKs. In human cancer, recent reports have described activating mutations in the PIK3CA gene encoding p110alpha, and inactivating mutations in the phosphatase and tensin homologue (PTEN) gene, a tumour suppressor and antagonist of the PI3K pathway. The PIK3CA mutations described in cancer constitutively activate p110alpha and, when expressed in cells drive oncogenic transformation. Moreover, these mutations cause the constitutive activation of downstream signaling molecules such as Akt/protein kinase B (PKB), mammalian target of rapamycin (mTOR) and ribosomal protein S6 kinase (S6K) that is commonly observed in cancer cells. In addition to p110alpha, the other isoforms of the PI3K family may also play a role in human cancer, although their individual functions remain to be precisely identified. In this review we will discuss the evidence implicating individual PI3K isoforms in human cancer and their potential as drug targets in this context.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 201–400 of 484
Altomare, D. A., Wang, H. Q., Skele, K. L., Rienzo, A. D., Klein-Szanto, A. J., Godwin, A. K., & Testa, J. R. (2004) · Oncogene · doi:10.1038/sj.onc.1207721 · Cited by 412
Transformation of Chicken Cells by the Gene Encoding the Catalytic Subunit of PI 3-Kinase
Chang, H. W., Aoki, M., Fruman, D., Auger, K. R., Bellacosa, A., Tsichlis, P. N., Cantley, L. C., Roberts, T. M., & Vogt, P. K. (1997) · Science · doi:10.1126/science.276.5320.1848 · Cited by 412
The PTEN, Mdm2, p53 tumor suppressor–oncoprotein network
Mayo, L. D., & Donner, D. B. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02166-7 · Cited by 410
Skorski, T., Kanakaraj, P., Nieborowska-Skorska, M., Ratajczak, M., Wen, S., Zon, G., Gewirtz, A., Perussia, B., & Calabretta, B. (1995) · Blood · doi:10.1182/blood.v86.2.726.bloodjournal862726 · Cited by 404
Phosphatidylinositol 3-Kinase Couples the Interleukin-2 Receptor to the Cell Cycle Regulator E2F
Brennan, P., Babbage, J. W., Burgering, B. M. T., Groner, B., Reif, K., & Cantrell, D. A. (1997) · Immunity · doi:10.1016/s1074-7613(00)80388-x · Cited by 404
Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor.
Lin, H.-K., Yeh, S., Kang, H.-Y., & Chang, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121173298 · Cited by 401
Survival of acute myeloid leukemia cells requires PI3 kinase activation
Xu, Q., Simpson, S.-E., Scialla, T. J., Bagg, A., & Carroll, M. (2003) · Blood · doi:10.1182/blood-2002-11-3429 · Cited by 394
Helliwell, S. B., Wagner, P., Kunz, J., Deuter-Reinhard, M., Henriquez, R., & Hall, M. N. (1994) · Molecular Biology of the Cell · doi:10.1091/mbc.5.1.105 · Cited by 390
Rhebbing up mTOR: New Insights on TSC1 and TSC2, and the Pathogenesis of Tuberous Sclerosis
Kwiatkowski, D. J. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.5.446 · Cited by 387 · cited 2×
“Tuberous sclerosis (TSC) is an autosomal dominant disorder characterized by the formation of hamartomas in a wide range of human tissues [224].”
BackgroundAntitumor Activity of ZSTK474, a New Phosphatidylinositol 3-Kinase Inhibitor
Yaguchi, S.-I., Fukui, Y., Koshimizu, I., Yoshimi, H., Matsuno, T., Gouda, H., Hirono, S., Yamazaki, K., & Yamori, T. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj133 · Cited by 387
Yuan, Z. Q., Sun, M., Feldman, R. I., Wang, G., Ma, X.-L., Jiang, C., Coppola, D., Nicosia, S. V., & Cheng, J. Q. (2000) · Oncogene · doi:10.1038/sj.onc.1203598 · Cited by 384
Akt Activation Promotes Degradation of Tuberin and FOXO3a via the Proteasome
Plas, D. R., & Thompson, C. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213069200 · Cited by 377
The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas
Chakravarti, A., Zhai, G., Suzuki, Y., Sarkesh, S., Black, P. M., Muzikansky, A., & Loeffler, J. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.193 · Cited by 377
Rare cancer-specific mutations in PIK3CA show gain of function
Gymnopoulos, M., Elsliger, M.-A., & Vogt, P. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701005104 · Cited by 376
p110δ, a novel phosphoinositide 3-kinase in leukocytes
Vanhaesebroeck, B., Welham, M. J., Kotani, K., Stein, R., Warne, P. H., Zvelebil, M. J., Higashi, K., Volinia, S., Downward, J., & Waterfield, M. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4330 · Cited by 376
Kitamura, T., Kitamura, Y., Kuroda, S., Hino, Y., Ando, M., Kotani, K., Konishi, H., Matsuzaki, H., Kikkawa, U., Ogawa, W., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6286 · Cited by 376
Yang, L., Dan, H. C., Sun, M., Liu, Q., Sun, X.-M., Feldman, R. I., Hamilton, A. D., Polokoff, M., Nicosia, S. V., Herlyn, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0343 · Cited by 371
Functional Analysis of PIK3CA Gene Mutations in Human Colorectal Cancer
Ikenoue, T., Kanai, F., Hikiba, Y., Obata, T., Tanaka, Y., Imamura, J., Ohta, M., Jazag, A., Guleng, B., Tateishi, K., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4114 · Cited by 369
Restraining PI3K: mTOR signalling goes back to the membrane
Harrington, L. S., Findlay, G. M., & Lamb, R. F. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.11.003 · Cited by 366
Essential Role of Phosphoinositide 3-Kinase δ in Neutrophil Directional Movement
Sadhu, C., Masinovsky, B., Dick, K., Sowell, C. G., & Staunton, D. E. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2647 · Cited by 365
Essential Role for Protein Kinase B (PKB) in Insulin-induced Glycogen Synthase Kinase 3 Inactivation
van Weeren, P. C., de Bruyn, K. M. T., de Vries-Smits, A. M. M., van Lint, J., & Burgering, B. M. T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13150 · Cited by 365
Akt Phosphorylation and Gefitinib Efficacy in Patients With Advanced Non-Small-Cell Lung Cancer
Cappuzzo, F., Magrini, E., Ceresoli, G. L., Bartolini, S., Rossi, E., Ludovini, V., Gregorc, V., Ligorio, C., Cancellieri, A., Damiani, S., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh217 · Cited by 362
Hu, L., Hofmann, J., Lu, Y., Mills, G. B., & Jaffe, R. B. (2002) · PubMed · Cited by 361
Anderson, K. E., Coadwell, J., Stephens, L. R., & Hawkins, P. T. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70274-x · Cited by 360
Interleukin 3-dependent survival by the Akt protein kinase
Songyang, Z., Baltimore, D., Cantley, L. C., Kaplan, D. R., & Franke, T. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11345 · Cited by 360
Prigent, S. A., & Gullick, W. J. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06577.x · Cited by 359
Blume-Jensen, P., Janknecht, R., & Hunter, T. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70302-1 · Cited by 356
Kohn, A. D., Kovacina, K. S., & Roth, R. A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00103.x · Cited by 355
PTEN Protects p53 from Mdm2 and Sensitizes Cancer Cells to Chemotherapy
Mayo, L. D., Dixon, J. E., Durden, D. L., Tonks, N. K., & Donner, D. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108302200 · Cited by 351
Stack, J. H., Herman, P. K., Schu, P. V., & Emr, S. D. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05867.x · Cited by 351
Recent advances in the protein kinase B signaling pathway
Woodgett, J. R. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.02.010 · Cited by 351
Gupta, A., McKenna, W. G., Weber, C. N., Feldman, M. D., Goldsmith, J. D., Mick, R., Machtay, M. X., Rosenthal, D. I., Bakanauskas, V. J., Cerniglia, G. J., et al. (2002) · PubMed · Cited by 343
Mutation of the PIK3CA Gene in Anaplastic Thyroid Cancer
García-Rostán, G., Costa, A. M., Pereira-Castro, I., Salvatore, G., Hernandez, R., Hermsem, M. J. A., Herrero, A., Fusco, A., Cameselle-Teijeiro, J., & Santoro, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4259 · Cited by 338
Mutations of PIK3CA in Anaplastic Oligodendrogliomas, High-Grade Astrocytomas, and Medulloblastomas
Broderick, D. K., Di, C., Parrett, T. J., Samuels, Y. R., Cummins, J. M., McLendon, R. E., Fults, D. W., Velculescu, V. E., Bigner, D. D., & Yan, H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1170 · Cited by 337
Maity, A. M., Pore, N., Lee, J. S. H., Solomon, D., & O’Rourke, D. M. (2000) · PubMed · Cited by 333
PI 3-kinase: structural and functional analysis of intersubunit interactions.
Dhand, R., Hara, K., Hiles, I., Bax, B., Gout, I., Panayotou, G., Fry, M. J., Yonezawa, K., Kasuga, M., & Waterfield, M. D. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06289.x · Cited by 329
Kau, T. R., Schroeder, F., Ramaswamy, S., Wojciechowski, C. L., Zhao, J. J., Roberts, T. M., Clardy, J., Sellers, W. R., & Silver, P. A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00303-9 · Cited by 329
The activation of phosphatidylinositol 3-kinase by Ras
Kodaki, T., Woscholski, R., Hallberg, B., Rodriguez-Viciana Julian Downward, P., & Parker, P. J. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00177-9 · Cited by 329
Isakoff, S. J., Cardozo, T., Andreev, J., Li, Z., Ferguson, K. M., Abagyan, R., Lemmon, M. A., Aronheim, A., & Skolnik, E. Y. (1998) · The EMBO Journal · doi:10.1093/emboj/17.18.5374 · Cited by 324
Zhao, J. J., Liu, Z., Wang, L., Shin, E., Loda, M. F., & Roberts, T. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508988102 · Cited by 324
Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression
Kwabi-Addo, B., Giri, D., Schmidt, K., Podsypanina, K., Parsons, R., Greenberg, N., & Ittmann, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201167798 · Cited by 323
Lu, Y., Lin, Y.-Z., LaPushin, R., Cuevas, B., Fang, X., Yu, S. X., Davies, M. A., Khan, H., Furui, T., Mao, M., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1203183 · Cited by 322
Ihle, N. T., Williams, R., Chow, S., Chew, W., Berggren, M. I., Paine-Murrieta, G., Minion, D. J., Halter, R. J., Wipf, P., Abraham, R., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.763.3.7 · Cited by 313
(2000) · PubMed · Cited by 310
Volinia, S., Dhand, R., Vanhaesebroeck, B., MacDougall, L. K., Stein, R., Zvelebil, M. J., Domin, J., Panaretou, C., & Waterfield, M. D. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07340.x · Cited by 307
Li, J., Simpson, L., Takahashi, M., Miliaresis, C., Myers, M. P., Tonks, N. K., & Parsons, R. E. (1998) · PubMed · Cited by 306
Moscatello, D. K., Holgado-Madruga, M., Emlet, D. R., Montgomery, R. B., & Wong, A. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.200 · Cited by 305
The phosphoinositide (PI) 3-kinase family
Foster, F. M., Traer, C. J., Abraham, S. M., & Fry, M. J. (2003) · Journal of Cell Science · doi:10.1242/jcs.00609 · Cited by 305
A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt
Aoki, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011528498 · Cited by 303
Goel, A., Arnold, C. N., Niedzwiecki, D., Carethers, J. M., Dowell, J. M., Wasserman, L., Compton, C., Mayer, R. J., Bertagnolli, M. M., & Boland, C. R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-2401-2 · Cited by 302
Krugmann, S., Anderson, K. E., Ridley, S. H., Risso, N., McGregor, A., Coadwell, J., Davidson, K., Eguinoa, A., Ellson, C. D., Lipp, P., et al. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00434-3 · Cited by 302
Whitman, M., Kaplan, D., Roberts, T., & Cantley, L. (1987) · Biochemical Journal · doi:10.1042/bj2470165 · Cited by 300
Overexpression and overactivation of Akt in thyroid carcinoma.
Ringel, M. D., Hayre, N., Saito, J., Saunier, B., Schuppert, F., Burch, H., Bernet, V., Burman, K. D., Kohn, L. D., & Saji, M. (2001) · PubMed · Cited by 297
The Akt kinase: Molecular determinants of oncogenicity
Aoki, M., Batista, O., Bellacosa, A., Tsichlis, P., & Vogt, P. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14950 · Cited by 296
Disruption of PDGF Receptor Trafficking by Mutation of Its PI-3 Linase Binding Sites
Joly, M., Kazlauskas, A., Fay, F. S., & Corvera, S. (1994) · Science · doi:10.1126/science.8303278 · Cited by 296
Pene, F., Claessens, Y.-E., Muller, O., Viguié, F., Mayeux, P., Dreyfus, F., Lacombe, C., & Bouscary, D. (2002) · Oncogene · doi:10.1038/sj.onc.1205923 · Cited by 295
Condliffe, A. M. (2005) · Blood · doi:10.1182/blood-2005-03-0944 · Cited by 295
Pten constrains centroacinar cell expansion and malignant transformation in the pancreas
Stanger, B. Z., Stiles, B., Lauwers, G. Y., Bardeesy, N., Mendoza, M., Wang, Y., Greenwood, A., Cheng, K.-H., McLaughlin, M., Brown, D., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.07.015 · Cited by 294
Pérez-Tenorio, G., Alkhori, L., Olsson, B., Waltersson, M. A., Nordenskjöld, B., Rutqvist, L. E., Skoog, L., & Stål, O. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1609 · Cited by 292
Obermeier, A., Lammers, R., Wiesmüller, K. H., Jung, G., Schlessinger, J., & Ullrich, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49410-6 · Cited by 290
She, Q., Solit, D. B., Basso, A., & Moasser, M. M. (2003) · PubMed · Cited by 287
The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis
Hamada, K., Sasaki, T., Koni, P. A., Natsui, M., Kishimoto, H., Sasaki, J., Yajima, N., Horie, Y., Hasegawa, G., Naito, M., et al. (2005) · Genes & Development · doi:10.1101/gad.1308805 · Cited by 287
Weng, L., Smith, W. M., Dahia, P. L. M., Ziebold, U., Gil, E., Lees, J. A., & Eng, C. (1999) · PubMed · Cited by 285
Hutchinson, J., Jin, J., Cardiff, R. D., Woodgett, J. R., & Muller, W. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.6.2203-2212.2001 · Cited by 280
Escobedo, J. A., Kaplan, D. R., Kavanaugh, W. M., Turck, C. W., & Williams, L. T. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.2.1125 · Cited by 279
Epigenetic Silencing of the PTEN Gene in Melanoma
Mirmohammadsadegh, A., Marini, A., Nambiar, S., Hassan, M., Tannapfel, A., Ruzicka, T., & Hengge, U. R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0384 · Cited by 279
Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase
Zhao, J. J., Gjoerup, O. V., Subramanian, R. R., Cheng, Y., Chen, W., Roberts, T. M., & Hahn, W. C. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00088-6 · Cited by 279
Inhibitors of mTOR reverse doxorubicin resistance conferred by PTEN status in prostate cancer cells.
Grünwald, V., deGraffenried, L. A., Russel, D., Friedrichs, W. E., Ray, R. B., & Hidalgo, M. M. (2002) · PubMed · Cited by 279
Forkhead transcription factors contribute to execution of the mitotic programme in mammals
Alvarez, B., Martínez-A., C., Burgering, B. M. T., & Carrera, A. C. (2001) · Nature · doi:10.1038/35099574 · Cited by 277
Troussard, A. A., Mawji, N. M., Ong, C., Mui, A., St.-Arnaud, R., & Dedhar, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303083200 · Cited by 276
Oncogenic Ras and its role in tumor cell invasion and metastasis
Campbell, P. M., & Der, C. J. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.09.015 · Cited by 275
Huang, W.-C., & Chen, C.-C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6592-6602.2005 · Cited by 275
Hayakawa, J., Ohmichi, M., Kurachi, H., Kanda, Y., Hisamoto, K., Nishio, Y., Adachi, K., Tasaka, K., Kanzaki, T., & Murata, Y. (2000) · PubMed · Cited by 274
Regulation and Physiological Roles of Serum- and Glucocorticoid-Induced Protein Kinase Isoforms
Lang, F., & Cohen, P. (2001) · Science's STKE · doi:10.1126/stke.2001.108.re17 · Cited by 274
(2001) · PubMed · Cited by 270
Davies, M. A., Lu, Y., Sano, T., Fang, X., Tang, P., LaPushin, R., Koul, D., Bookstein, R., Stokoe, D., Yung, W. K. A., et al. (1998) · PubMed · Cited by 270
(2003) · PubMed · Cited by 269
Jimenez, C. (1998) · The EMBO Journal · doi:10.1093/emboj/17.3.743 · Cited by 269
Kang, S., Denley, A., Vanhaesebroeck, B., & Vogt, P. K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510772103 · Cited by 267
Phosphoinositide 3-kinase activates Rac by entering in a complex with Eps8, Abi1, and Sos-1
Innocenti, M., Frittoli, E., Ponzanelli, I., Falck, J. R., Brachmann, S. M., Di Fiore, P. P., & Scita, G. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200206079 · Cited by 264
Bondar, V. M., Sweeney‐Gotsch, B., Andreeff, M., Mills, G. B., & McConkey, D. J. (2002) · PubMed · Cited by 263
Dhawan, P., Singh, A. B., Ellis, D. L., & Richmond, A. J. (2002) · PubMed · Cited by 260
Hu, P., Mondino, A., Skolnik, E. Y., & Schlessinger, J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7677 · Cited by 260
Kurosu, H., Maehama, T., Okada, T., Yamamoto, T., Hoshino, S.-I., Fukui, Y., Ui, M., Hazeki, O., & Katada, T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24252 · Cited by 260
Klippel, A., Escobedo, M.-A., Wachowicz, M. S., Apell, G., Brown, T. W., Giedlin, M. A., Kavanaugh, W. M., & Williams, L. T. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.5699 · Cited by 258
Graziani, A., Gramaglia, D., Cantley, L. C., & Comoglio, P. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54536-1 · Cited by 257
Chun, K.-H., Kosmeder, J. W., Sun, S., Pezzuto, J. M., Lotan, R., Hong, W. K., & Lee, H.-Y. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.4.291 · Cited by 255
Chantry, D., Vojtek, A., Kashishian, A., Holtzman, D. A., Wood, C., Gray, P. W., Cooper, J. A., & Hoekstra, M. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19236 · Cited by 253
DOMIN, J., PAGES, F., VOLINIA, S., RITTENHOUSE, S. E., ZVELEBIL, M. J., STEIN, R. C., & WATERFIELD, M. D. (1997) · Biochemical Journal · doi:10.1042/bj3260139 · Cited by 251
Rottapel, R., Reedijk, M., Williams, D. E., Lyman, S. D., Anderson, D. M., Pawson, T., & Bernstein, A. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.6.3043 · Cited by 250
Conditional loss of PTEN leads to testicular teratoma and enhances embryonic germ cell production
Kimura, T., Suzuki, A., Fujita, Y., Yomogida, K., Lomeli, H., Asada, N., Ikeuchi, M., Nagy, A., Mak, T. W., & Nakano, T. (2003) · Development · doi:10.1242/dev.00392 · Cited by 245
Hawkins, P. T., Jackson, T. R., & Stephens, L. R. (1992) · Nature · doi:10.1038/358157a0 · Cited by 245
Qiu, Y., Robinson, D., Pretlow, T. G., & Kung, H.-J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3644 · Cited by 245
Sujobert, P. (2005) · Blood · doi:10.1182/blood-2004-08-3225 · Cited by 245
Itoh, N., Semba, S., Ito, M., Takeda, H., Kawata, S., & Yamakawa, M. (2002) · Cancer · doi:10.1002/cncr.10591 · Cited by 243
Pons, S., Asano, T., Glasheen, E., Miralpeix, M., Zhang, Y., Fisher, T. L., Myers, M. G., Sun, X. J., & White, M. F. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4453 · Cited by 243
Activated Phosphatidylinositol 3-Kinase and Akt Kinase Promote Survival of Superior Cervical Neurons
Philpott, K. L., McCarthy, M. J., Klippel, A., & Rubin, L. L. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.3.809 · Cited by 242
Regulation of nuclear translocation of Forkhead transcription factor AFX by protein kinase B
Takaishi, H., Konishi, H., Matsuzaki, H., Ono, Y., Shirai, Y., Saito, N., Kitamura, T., Ogawa, W., Kasuga, M., Kikkawa, U., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.11836 · Cited by 238
Martin, S. S., Haruta, T., Morris, A. J., Klippel, A., Williams, L. T., & Olefsky, J. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17605 · Cited by 238
The Ras radiation resistance pathway.
Gupta, A. K., Bakanauskas, V. J., Cerniglia, G. J., Cheng, Y., Bernhard, E. J., Muschel, R. J., & McKenna, W. G. (2001) · PubMed · Cited by 238
Kazlauskas, A., & Cooper, J. A. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07527.x · Cited by 237
Serunian, L. A., Haber, M. T., Fukui, T., Kim, J. W., Rhee, S. G., Lowenstein, J. M., & Cantley, L. C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84645-8 · Cited by 236
Alvarez-Tejado, M., Naranjo-Suárez, S., Jiménez, C., Carrera, A. C., Landázuri, M. O., & del Peso, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011688200 · Cited by 235
Aoki, M., Jiang, H., & Vogt, P. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405454101 · Cited by 234
Chakravarti, A., Chakladar, A., Delaney, M. A., Latham, D. E., & Loeffler, J. S. (2002) · PubMed · Cited by 234
Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines.
Tsao, H., Zhang, X., Fowlkes, K., & Haluska, F. G. (2000) · PubMed · Cited by 234
Soltoff, S. P., Rabin, S. L., Cantley, L. C., & Kaplan, D. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41950-3 · Cited by 231
Reedijk, M., Liu, X., van der Geer, P., Letwin, K., Waterfield, M. D., Hunter, T., & Pawson, T. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05181.x · Cited by 229
Characterization of p150, an Adaptor Protein for the Human Phosphatidylinositol (PtdIns) 3-Kinase
Panaretou, C., Domin, J., Cockcroft, S., & Waterfield, M. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2477 · Cited by 228
Fedi, P., Pierce, J. H., di Fiore, P. P., & Kraus, M. H. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.492 · Cited by 228
Multiple Independent Inputs Are Required for Activation of the p70 S6 Kinase
Weng, Q.-P., Andrabi, K., Kozlowski, M. T., Grove, J. R., & Avruch, J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2333 · Cited by 225
Phosphatidylinositol 3-kinase regulates Raf1 through Pak phosphorylation of serine 338
Chaudhary, A., King, W. G., Mattaliano, M. D., Frost, J. A., Diaz, B., Morrison, D. K., Cobb, M. H., Marshall, M. S., & Brugge, J. S. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00475-9 · Cited by 225
Promoter methylation of the PTEN gene is a common molecular change in breast cancer
García, J. M., Silva, J., Peña, C., Garcia, V., Rodríguez, R., Cruz, M. A., Cantos, B., Provencio, M., España, P., & Bonilla, F. (2004) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20062 · Cited by 224
Zhao, J. J., Cheng, H., Jia, S., Wang, L., Gjoerup, O. V., Mikami, A., & Roberts, T. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607899103 · Cited by 224
Mamillapalli, R., Gavrilova, N., Mihaylova, V. T., Tsvetkov, L. M., Wu, H., Zhang, H., & Sun, H. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00065-3 · Cited by 224
Segouffin-Cariou, C., & Billaud, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3568 · Cited by 223
Massion, P. P., Kuo, W.-L., Stokoe, D., Olshen, A. B., TRESELER, P. A., Chin, K., Chen, C., Polikoff, D., Jain, A. N., Pinkel, D., et al. (2002) · PubMed · Cited by 222
PTEN Induces Cell Cycle Arrest by Decreasing the Level and Nuclear Localization of Cyclin D1
Radu, A., Neubauer, V., Akagi, T., Hanafusa, H., & Georgescu, M.-M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.17.6139-6149.2003 · Cited by 221
Narita, Y., Nagane, M., Mishima, K., Huang, H.-J. S., Furnari, F. B., & Cavenee, W. K. (2002) · PubMed · Cited by 221
Gesbert, F., Sellers, W. R., Signoretti, S., Loda, M., & Griffin, J. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007291200 · Cited by 220
p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas
Singh, B., Reddy, P. G., Goberdhan, A., Walsh, C., Dao, S., Ngai, I., Chou, T. C., O-charoenrat, P., Levine, A. J., Rao, P. H., et al. (2002) · Genes & Development · doi:10.1101/gad.973602 · Cited by 218
Activation of phosphatidylinositol 3-kinase in cells expressing abl oncogene variants.
Varticovski, L., Daley, G. Q., Jackson, P., Baltimore, D., & Cantley, L. C. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.2.1107 · Cited by 210
Thompson, J. E., & Thompson, C. B. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.103 · Cited by 206
Hypoxia‐inducible factor‐1 and oncogenic signalling
Bárdos, J. I., & Ashcroft, M. (2004) · BioEssays · doi:10.1002/bies.20002 · Cited by 206
ErbB3 Is Involved in Activation of Phosphatidylinositol 3-Kinase by Epidermal Growth Factor
Soltoff, T. P., Carraway, K. L., Prigent, S. A., Gullick, W. G., & Cantley, L. C. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.3550-3558.1994 · Cited by 205
Welsh, G. I., Foulstone, E. J., Young, S. W., Tavaré, J. M., & Proud, C. G. (1994) · Biochemical Journal · doi:10.1042/bj3030015 · Cited by 204
Weng, Q. P., Andrabi, K., Klippel, A., Kozlowski, M. T., Williams, L. T., & Avruch, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5744 · Cited by 204
PIK3CA Mutations in Head and Neck Squamous Cell Carcinoma
Qiu, W., Schönleben, F., Li, X., Ho, D. J., Close, L. G., Manolidis, S., Bennett, B. P., & Su, G. H. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2173 · Cited by 201
Webster, M. A., Hutchinson, J. N., Rauh, M. J., Muthuswamy, S. K., Anton, M., Tortorice, C. G., Cardiff, R. D., Graham, F. L., Hassell, J. A., & Muller, W. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.2344 · Cited by 200
Cytokine-regulated expression of survivinin myeloid leukemia
Carter, B. Z., Milella, M., Altieri, D. C., & Andreeff, M. (2001) · Blood · doi:10.1182/blood.v97.9.2784 · Cited by 197
Chen, E. Y., Mazure, N. M., Cooper, J. A., & Giaccia, A. J. (2001) · PubMed · Cited by 194
Min, Y. H., Eom, J. I., Cheong, J. W., Maeng, H. O., Kim, J. Y., Jeung, H. K., Lee, S. T., Lee, M. H., Hahn, J. S., & Ko, Y. W. (2003) · Leukemia · doi:10.1038/sj.leu.2402874 · Cited by 192
Eves, E. M., Xiong, W., Bellacosa, A., Kennedy, S. G., Tsichlis, P. N., Rosner, M. R., & Hay, N. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.2143 · Cited by 188
Integration of Growth Factor and Nutrient Signaling
Shamji, A. F., Nghiem, P., & Schreiber, S. L. (2003) · Molecular Cell · doi:10.1016/j.molcel.2003.08.016 · Cited by 186
Booker, G. W., Gout, I., Kristina^Downing, A., Driscoll, P. C., Boyd, J., Waterfield, M. D., & Campbell, I. D. (1993) · Cell · doi:10.1016/0092-8674(93)90259-s · Cited by 186
Neshat, M. S., Raitano, A. B., Wang, H.-G., Reed, J. C., & Sawyers, C. L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1179-1186.2000 · Cited by 185
Mcglade, C. J., Ellis, C., Reedijk, M., Anderson, D., Mbamalu, G., Reith, A. D., Panayotou, G., End, P., Bernstein, A., Kazlauskas, A., et al. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.991-997.1992 · Cited by 185
Byun, D., Cho, K., Ryu, B., Lee, M., Park, J., Chae, K., Kim, H., & Chi, S. (2003) · International Journal of Cancer · doi:10.1002/ijc.10962 · Cited by 184
Li, Z., Wahl, M. I., Eguinoa, A., Stephens, L. R., Hawkins, P. T., & Witte, O. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13820 · Cited by 184
Agarwal, A., Das, K., Lerner, N., Sathe, S., Cicek, M., Casey, G., & Sizemore, N. (2005) · Oncogene · doi:10.1038/sj.onc.1208296 · Cited by 181
Persistent Activation of the Akt Pathway in Head and Neck Squamous Cell Carcinoma
Amornphimoltham, P., Sriuranpong, V., Patel, V., Benavides, F., Conti, C. J., Sauk, J., Sausville, E. A., Molinolo, A. A., & Gutkind, J. S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0249 · Cited by 181
Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival.
Ermoian, R. P., Furniss, C. S., Lamborn, K. R., Basila, D., Berger, M. S., GOTTSCHALK, A. R., Nicholas, M. K., Stokoe, D., & Haas-Kogan, D. A. (2002) · PubMed · Cited by 180
Semba, S., Itoh, N., Ito, M., Harada, M., & Yamakawa, M. (2002) · PubMed · Cited by 180
R.‐Borlado, L., Redondo, C., Alvarez, B., Jimenez, C., Criado, L. M., Flores, J., Marcos, M. A. R., Martinez‐A., C., Balomenos, D., & Carrera, A. C. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.895 · Cited by 175
Mabuchi, S., Ohmichi, M., Kimura, A., Hisamoto, K., Hayakawa, J., Nishio, Y., Adachi, K., Takahashi, K., Arimoto-Ishida, E., Nakatsuji, Y., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204042200 · Cited by 174
DeFeo-Jones, D., Barnett, S. F., Fu, S., Hancock, P. J., Haskell, K. M., Leander, K. R., McAvoy, E., Robinson, R. G., Duggan, M. E., Lindsley, C. W., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.271.4.2 · Cited by 173
Collis, S. J., Swartz, M. J., Nelson, W. G., & DeWeese, T. L. (2003) · PubMed · Cited by 172
Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay.
Han, S., Kato, H., Kato, S., Suzuki, T., Shibata, H., Ishii, S., Shiiba, K.-I., Matsuno, S., Kanamaru, R., & Ishioka, C. (2000) · PubMed · Cited by 170
Krystal, G. W., Sulanke, G., & Litz, J. (2002) · PubMed · Cited by 170
Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110delta.
Sawyer, C., Sturge, J., Bennett, D. C., O’Hare, M. J., Allen, W. E., Bain, J., Jones, G. E., & Vanhaesebroeck, B. (2003) · PubMed · Cited by 169
Talmage, D. A., Freund, R., Young, A. T., Dahl, J., Dawe, C. J., & Benjamin, T. L. (1989) · Cell · doi:10.1016/0092-8674(89)90869-6 · Cited by 168
Giorgetti, S., Ballotti, R., Kowalski-Chauvel, A., Tartare, S., & Van Obberghen, E. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53183-5 · Cited by 167
Chan, T. O., Rodeck, U., Chan, A. M.-L., Kimmelman, A. C., Rittenhouse-Simmons, S., Panayotou, G., & Tsichlis, P. N. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00033-8 · Cited by 167
Pore, N., Liu, S., Haas-Kogan, D. A., O’Rourke, D. M., & Maity, A. M. (2003) · PubMed · Cited by 167
Structure of an SH2 domain of the p85α subunit of phosphatidylinositol-3-OH kinase
Booker, G. W., Breeze, A. L., Downing, A. K., Panayotou, G., Gout, I., Waterfield, M. D., & Campbell, I. D. (1992) · Nature · doi:10.1038/358684a0 · Cited by 166
Inukai, K., Funaki, M., Ogihara, T., Katagiri, H., Kanda, A., Anai, M., Fukushima, Y., Hosaka, T., Suzuki, M., Shin, B.-C., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7873 · Cited by 166
Sun, H., King, A. J., Diaz, H. B., & Marshall, M. S. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00359-6 · Cited by 165
Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma.
Kanamori, Y., Kigawa, J., Itamochi, H., Shimada, M., Takahashi, M., Kamazawa, S., Sato, S., Akeshima, R., & Terakawa, N. (2001) · PubMed · Cited by 165
Interactions between Ras1, dMyc, and dPI3K signaling in the developing Drosophila wing
Prober, D. A., & Edgar, B. A. (2002) · Genes & Development · doi:10.1101/gad.991102 · Cited by 164
PIK3CA Mutations in Intraductal Papillary Mucinous Neoplasm/Carcinoma of the Pancreas
Schönleben, F., Qiu, W., Ciau, N. T., Ho, D. J., Li, X., Allendorf, J. D., Remotti, H. E., & Su, G. H. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0292 · Cited by 164
Gratacap, M.-P., Payrastre, B., Viala, C., Mauco, G., Plantavid, M., & Chap, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.38.24314 · Cited by 163
Stephens, L., Eguinoa, A., Corey, S., Jackson, T., & Hawkins, P. T. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05880.x · Cited by 162
Terakawa, N., Kanamori, Y., & Yoshida, S. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100203 · Cited by 161
Targeting the molecular target of rapamycin (mTOR)
Rowinsky, E. K. (2004) · Current Opinion in Oncology · doi:10.1097/01.cco.0000143964.74936.d1 · Cited by 160
Phosphatidylinositol-3 kinase inhibitors enhance the anti-leukemia effect of STI571
Klejman, A., Rushen, L., Morrione, A., Słupianek, A., & Skórski, T. (2002) · Oncogene · doi:10.1038/sj.onc.1205724 · Cited by 160
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten
Backman, S. A., Ghazarian, D., So, K., Sanchez, O., Wagner, K.-U., Hennighausen, L., Suzuki, A., Tsao, M.-S., Chapman, W. B., Stambolic, V., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308217100 · Cited by 159
Identification of two SH3-binding motifs in the regulatory subunit of phosphatidylinositol 3-kinase.
Kapeller, R., Prasad, K. V., Janßen, O., Hou, W.-S., Schaffhausen, B. S., Rudd, C. E., & Cantley, L. C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42115-6 · Cited by 158
Altomare, D. A., You, H., Xiao, G.-H., Ramos-Nino, M. E., Skele, K. L., De Rienzo, A., Jhanwar, S. C., Mossman, B. T., Kane, A. B., & Testa, J. R. (2005) · Oncogene · doi:10.1038/sj.onc.1208744 · Cited by 158
Andreu, E. J., Lledó, E., Poch, E., Ivorra, C., Albero, M. P., Martinez-Climent, J. A., Montiel‐Duarte, C., Rifón, J., Pérez‐Calvo, J., Arbona, C., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1357 · Cited by 157
Bacus, S. S., Altomare, D. A., Lyass, L., Chin, D. M., Farrell, M. P., Gurova, K. V., Gudkov, A. V., & Testa, J. R. (2002) · Oncogene · doi:10.1038/sj.onc.1205438 · Cited by 157
Cancer-specific mutations in phosphatidylinositol 3-kinase
Vogt, P. K., Kang, S., Elsliger, M., & Gymnopoulos, M. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.05.005 · Cited by 157
Phosphoinositide 3‐kinase controls early and late events in mammalian cell division
García, Z., Kumar, A., Marqués, M., Cortés, I., & Carrera, A. C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600967 · Cited by 155
Billottet, C., Grandage, V., Gale, R. E., Quattropani, A., Rommel, C., Vanhaesebroeck, B., & Khwaja, A. (2006) · Oncogene · doi:10.1038/sj.onc.1209670 · Cited by 155
Mouse p170 Is a Novel Phosphatidylinositol 3-Kinase Containing a C2 Domain
Virbasius, J. V., Guilherme, A., & Czech, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.23.13304 · Cited by 154
Ihle, N. T., Paine-Murrieta, G. D., Berggren, M. I., Baker, A. F., Tate, W. R., Wipf, P., Abraham, R. T., Kirkpatrick, D. L., & Powis, G. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0149 · Cited by 154
Kuo, M., Chuang, S., Lin, M., & Yang, S.-Y. (2001) · Oncogene · doi:10.1038/sj.onc.1204140 · Cited by 153
Woenckhaus, J., Steger, K., Werner, E., Fenic, I., Gamerdinger, U., Dreyer, T., & Stahl, U. (2002) · The Journal of Pathology · doi:10.1002/path.1207 · Cited by 152
Chian, R., Young, S. M., Danilkovitch‐Miagkova, A., Rönnstrand, L., Leonard, E. J., Ferrao, P., Ashman, L. K., & Linnekin, D. (2001) · Blood · doi:10.1182/blood.v98.5.1365 · Cited by 149
Price, B. D., & Youmell, M. B. (1996) · PubMed · Cited by 147
Moore, S. M., Rintoul, R. C., Walker, T. R., Chilvers, E. R., Haslett, C., & Sethi, T. (1998) · PubMed · Cited by 147
A specific combination of substrates is involved in signal transduction by the kit‐encoded receptor.
Lev, S., Givol, D., & Yarden, Y. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07993.x · Cited by 146
van der Geer, P., & Hunter, T. R. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06211.x · Cited by 145
MacDougall, L. K., Domin, J., & Waterfield, M. D. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00278-8 · Cited by 145
v-Crk activates the phosphoinositide 3-kinase/AKT pathway in transformation
Akagi, T., Shishido, T., Murata, K., & Hanafusa, H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140210297 · Cited by 143
Activation of Phosphoinositide 3-Kinase γ by Ras
Suire, S., Hawkins, P. T., & Stephens, L. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00933-8 · Cited by 143
Klippel, A., Escobedo, J. A., Fantl, W. J., & Williams, L. T. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.4.1451 · Cited by 143
Zhao, H., Dupont, J., Yakar, S., Karas, M., & LeRoith, D. (2004) · Oncogene · doi:10.1038/sj.onc.1207162 · Cited by 142
Selective role of PI3Kδ in neutrophil inflammatory responses
Sadhu, C., Dick, K. O., Tino, W. T., & Staunton, D. E. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01480-3 · Cited by 142
Loss of PTEN expression leading to high Akt activation in human multiple myelomas
Hyun, T. S., Yam, A., Pece, S., Xie, X., Zhang, J., Miki, T., Gutkind, J. S., & Li, W. (2000) · Blood · doi:10.1182/blood.v96.10.3560 · Cited by 137
Genetic Alterations of Phosphoinositide 3‐kinase Subunit Genes in Human Glioblastomas
Mizoguchi, M., Nutt, C. L., Mohapatra, G., & Louis, D. N. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00080.x · Cited by 136
Klinghoffer, R. A., Duckworth, B. C., Valius, M., Cantley, L. C., & Kazlauskas, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5905 · Cited by 136
Logan, S. K., Falasca, M., Hu, P. J., & Schlessinger, J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.10.5784 · Cited by 135
Yao, R., & Cooper, G. M. (1996) · PubMed · Cited by 135
Human Phosphoinositide 3-Kinase C2β, the Role of Calcium and the C2 Domain in Enzyme Activity
Arcaro, A., Volinia, S., Zvelebil, M., Stein, R. C., Watton, S. J., Layton, M. J., Gout, I. T., Ahmadi, K., Downward, J., & Waterfield, M. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.33082 · Cited by 134
Self-citationSlíva, D., Rizzo, M. T., & English, D. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109579200 · Cited by 134
Didichenko, S. A., Tilton, B., Hemmings, B. A., Ballmer‐Hofer, K., & Thelen, M. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70713-6 · Cited by 133
Mutation of the 9q34 gene TSC1 in sporadic bladder cancer
Hornigold, N., Devlin, J., Davies, A. M., Aveyard, J. S., Habuchi, T., & Knowles, M. A. (1999) · Oncogene · doi:10.1038/sj.onc.1202854 · Cited by 132
Su, J. D., Mayo, L. D., Donner, D. B., & Durden, D. L. (2003) · PubMed · Cited by 132
Transformation by v-Src: Ras-MAPK and PI3K-mTOR Mediate Parallel Pathways
Penuel, E. M., & Martin, G. S. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.6.1693 · Cited by 131
Grana, T. M., Rusyn, E. V., Zhou, H., Sartor, C. I., & Cox, A. D. (2002) · PubMed · Cited by 130
Cited by
PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside
Alzahrani, A. S. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.009 · Cited by 1,054
PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects
Miricescu, D., Totan, A., Stanescu-Spinu, I.-I., Badoiu, S. C., Stefani, C., & Greabu, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010173 · Cited by 845
Gastric cancer—molecular and clinical dimensions
Wadhwa, R., Song, S., Lee, J.-S., Yao, Y., Wei, Q., & Ajani, J. A. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.170 · Cited by 423
Almansour, N. M. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.836417 · Cited by 397
Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)
NITULESCU, G. M., MARGINA, D., JUZENAS, P., PENG, Q., OLARU, O. T., SALOUSTROS, E., FENGA, C., SPANDIDOS, D. A., LIBRA, M., & TSATSAKIS, A. M. (2016) · International Journal of Oncology · doi:10.3892/ijo.2015.3306 · Cited by 364
Metadata
- Authors
- Arcaro, A., & Guerreiro, A.
- Venue
- Current Genomics
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2007-08-01
- Volume
- 8
- Issue
- 5
- Pages
- 271-306
- ISSN
- 1389-2029 (ISSN-L)
- OpenAlex
- W2024611216
- Cited by
- 269
- References
- 484
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.